Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech News -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (20)	11/13/1999 9:20:00 AM
From: WTDEC	Respond to of 7143

Mike, here is some support that H. Pylori bacteria play a key role on some cancers: siliconinvestor.com <SNIP> Finally, important findings were presented showing the enhancement of polyp proliferation in the colon caused by H. pylori, the bacteria now associated with most stomach ulcers and with stomach cancer. It was concluded that H. pylori infection resulted in significant hypergastrinemia (abnormally high levels of gastrin), which resulted in enhanced polyp proliferation. The polyps, in turn, become malignant and progress to cancer. The study both confirmed the recent epidemiological findings demonstrating a relationship between H. pylori and colorectal cancer; and highlights the need to reassess the safety of hypergastrinemia. <SNIP>

To: Mike McFarland who wrote (20)	11/16/1999 1:55:00 PM
From: biowa	Read Replies (1) \| Respond to of 7143

Maybe we should still use leeches... Researchers at the University of Iowa found that purposely infecting inflammatory bowel disease patients with helminthic worms improved their symptoms. In fact, just one dose of the eggs of these normal human parasites in a sports drink caused the disease to go into remission in five of the six patients tested. Researchers were intrigued by the fact that inflammatory bowel disease, along with the related Crohn's disease and ulcerative colitis, has been on the rise since "improved" sanitation in the early part of this century began to eliminate the worms from the normal human gut flora in more developed nations. Apparently larger clinical trials are under way. Pure speculation, but what if the immune modulation that apparently causes this effect is systemic? Since many of the same agents that treat Crohn's disease are also used for RA, wouldn't it be scary if this also worked there. (Food for the ISIP, IMNX, CNTO and AMGN shorts <g>) biowa